Page last updated: 2024-11-04

sb 202190 and Myocardial Ischemia

sb 202190 has been researched along with Myocardial Ischemia in 6 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"Necrosis was assessed after 40 min of ischemia and 2 h of reperfusion using 2,3,5-triphenyltetrazolium chloride (TTC) staining and creatine kinase release."1.31Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning. ( Chen, W; Hou, J; Murphy, E; Schneider, S; Steenbergen, C, 2001)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clanachan, AS3
Jaswal, JS3
Gandhi, M3
Bottorff, DA1
Coughlin, J1
Finegan, BA3
Stone, JC1
Ritchie, RH1
Gordon, JM1
Woodman, OL1
Cao, AH1
Dusting, GJ1
Dyck, JR2
Schneider, S1
Chen, W1
Hou, J1
Steenbergen, C1
Murphy, E1
Moor, AN1
Gan, XT1
Karmazyn, M1
Fliegel, L1

Other Studies

6 other studies available for sb 202190 and Myocardial Ischemia

ArticleYear
Effects of inhibition of myocardial extracellular-responsive kinase and P38 mitogen-activated protein kinase on mechanical function of rat hearts after prolonged hypothermic ischemia.
    Transplantation, 2003, Jan-27, Volume: 75, Issue:2

    Topics: Animals; Enzyme Activation; Flavonoids; Hypothermia, Induced; Imidazoles; Male; Mitogen-Activated Pr

2003
Annexin-1 peptide Anx-1(2-26) protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia.
    British journal of pharmacology, 2005, Volume: 145, Issue:4

    Topics: Alkaloids; Analysis of Variance; Animals; Annexin A1; Benzophenanthridines; Cells, Cultured; Creatin

2005
p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:4

    Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Coronary Circulation; Enzyme Inhibitors; Glucose;

2007
Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:2

    Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Cardiotonic Agents; Disease Models, Animal; Gluco

2007
Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:2

    Topics: Animals; Enzyme Inhibitors; Glycolysis; Heart Rate; Hydrogen-Ion Concentration; Imidazoles; Ischemic

2001
Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium.
    The Journal of biological chemistry, 2001, May-11, Volume: 276, Issue:19

    Topics: Animals; Animals, Newborn; Cells, Cultured; Enzyme Inhibitors; Flavonoids; Heart; Heart Ventricles;

2001